Digestion | Inflammation Markers
Comprehensive Stool Analysis
Comprehensive Stool Analysis
Stool testing can provide useful information about specific aspects of digestive and intestinal health when markers are selected for a clear clinical purpose. Comprehensive Stool Analysis at Yoyime Wellness Clinic in Dubai is positioned around gastrointestinal function and conventional stool markers rather than microbiome mapping. Depending on symptoms, our clinician may consider markers related to intestinal inflammation, pancreatic digestive function, gastrointestinal bleeding, malabsorption or selected infectious causes. Results are interpreted individually and used to determine whether treatment, further investigation, imaging, endoscopy or specialist gastroenterology review is appropriate.
Benefits of Comprehensive Stool Analysis
Evaluates Digestive Function
Assesses Intestinal Inflammation
Directs Further Investigation
Recommended for Patients With
Persistent Bowel Changes
Possible Malabsorption
Intestinal Inflammation Concerns
Step-By-Step Procedure - Comprehensive Stool Analysis
Clinical Assessment
Our clinician reviews symptoms and determines which stool questions require investigation.
Previous Results
Earlier blood, stool, imaging and gastrointestinal findings are reviewed.
Marker Selection
Specific stool markers are selected according to the clinical presentation.
Collection Guidance
Instructions are provided for correct sample collection, storage and transport.
Stool Collection
The required sample is collected using the laboratory supplied collection materials.
Laboratory Testing
Selected digestive, inflammatory or other clinically relevant markers are measured.
Results Interpretation
Each result is interpreted alongside symptoms and existing clinical information.
Further Direction
Treatment, repeat testing, endoscopy or specialist referral is recommended when appropriate.
Have questions about Comprehensive Stool Analysis?
Message our team on WhatsApp for personalised guidance before you book.
- Evaluate digestive function and intestinal inflammation using clinically selected stool markers.
- Guide further investigation through focused analysis of gastrointestinal laboratory findings appropriately.
Frequently Asked Questions
Comprehensive Stool Analysis
Yoyime's Comprehensive Stool Analysis in Dubai uses clinically selected stool markers to investigate digestive function, intestinal inflammation and other specific gastrointestinal concerns.
Depending on symptoms, testing may include markers such as faecal calprotectin, pancreatic elastase, occult blood or selected investigations for malabsorption and gastrointestinal infection.
Faecal calprotectin is a stool marker of intestinal inflammation and can help distinguish an inflammatory process from some functional gastrointestinal disorders when interpreted with other clinical findings.
Faecal pancreatic elastase is used when exocrine pancreatic insufficiency is suspected and provides information about pancreatic digestive enzyme output.
No. At Yoyime, Comprehensive Stool Analysis is focused on digestive function and clinically validated stool markers, while GI-MAP is the dedicated quantitative PCR microbial DNA profiling service.
No. That separation is intentional. Patients specifically requiring GI-MAP microbial profiling should use the dedicated GI-MAP service rather than duplicating microbiome testing here.
No. An elevated calprotectin suggests intestinal inflammation but does not independently diagnose inflammatory bowel disease. Further clinical assessment, imaging or endoscopy may be required.
Selected stool markers can provide information about digestive or absorptive problems. For example, pancreatic elastase can support assessment of pancreatic insufficiency, while other tests may be selected according to symptoms.
No. Our clinician selects relevant markers according to symptoms and clinical questions rather than automatically performing every available stool test.
Cost depends on the stool markers selected and laboratory requirements. At Yoyime, our team explains the proposed panel and associated costs before testing.
